Jong-Ho Choi1, Yun-Suhk Suh2, Yunhee Choi3, Jiyeon Han3, Tae Han Kim1, Shin-Hoo Park1, Seong-Ho Kong1, Hyuk-Joon Lee1,4, Han-Kwang Yang1,4. 1. Department of General Surgery, Seoul National University Hospital, Daehak-ro 101, Jongno-gu, Seoul, 03080, Korea. 2. Department of General Surgery, Seoul National University Hospital, Daehak-ro 101, Jongno-gu, Seoul, 03080, Korea. ysksuh@snu.ac.kr. 3. Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea. 4. Cancer Research Institute, Seoul National University College of Medicine, Seoul, 110-744, Korea.
Abstract
BACKGROUND: The role of neutrophil-to-lymphocyte ratio (NLR) and preoperative prediction model in gastric cancer is controversial, while postoperative prognostic models are available. This study investigated NLR as a preoperative prognostic indicator in gastric cancer. METHODS: We reviewed patients with primary gastric cancer who underwent surgery during 2007-2010. Preoperative clinicopathologic factors were analyzed with their interaction and used to develop a prognosis prediction nomogram. That preoperative prediction nomogram was compared to a nomogram using pTNM or a historical postoperative prediction nomogram. The contribution of NLR to a preoperative nomogram was evaluated with integrated discrimination improvement (IDI). RESULTS: Using 2539 records, multivariable analysis revealed that NLR was one of the independent prognostic factors and had a significant interaction with only age among other preoperative factors (especially significant in patients < 50 years old). NLR was constantly significant between 1.1 and 3.1 without any distinctive cutoff value. Preoperative prediction nomogram using NLR showed a Harrell's C-index of 0.79 and an R2 of 25.2%, which was comparable to the C-index of 0.78 and 0.82 and R2 of 26.6 and 25.8% from nomogram using pTNM and a historical postoperative prediction nomogram, respectively. IDI of NLR to nomogram in the overall population was 0.65%, and that of patients < 50 years old was 2.72%. CONCLUSIONS: NLR is an independent prognostic factor for gastric cancer, especially in patients < 50 years old. A preoperative prediction nomogram using NLR can predict prognosis of gastric cancer as effectively as pTNM and a historical postoperative prediction nomogram.
BACKGROUND: The role of neutrophil-to-lymphocyte ratio (NLR) and preoperative prediction model in gastric cancer is controversial, while postoperative prognostic models are available. This study investigated NLR as a preoperative prognostic indicator in gastric cancer. METHODS: We reviewed patients with primary gastric cancer who underwent surgery during 2007-2010. Preoperative clinicopathologic factors were analyzed with their interaction and used to develop a prognosis prediction nomogram. That preoperative prediction nomogram was compared to a nomogram using pTNM or a historical postoperative prediction nomogram. The contribution of NLR to a preoperative nomogram was evaluated with integrated discrimination improvement (IDI). RESULTS: Using 2539 records, multivariable analysis revealed that NLR was one of the independent prognostic factors and had a significant interaction with only age among other preoperative factors (especially significant in patients < 50 years old). NLR was constantly significant between 1.1 and 3.1 without any distinctive cutoff value. Preoperative prediction nomogram using NLR showed a Harrell's C-index of 0.79 and an R2 of 25.2%, which was comparable to the C-index of 0.78 and 0.82 and R2 of 26.6 and 25.8% from nomogram using pTNM and a historical postoperative prediction nomogram, respectively. IDI of NLR to nomogram in the overall population was 0.65%, and that of patients < 50 years old was 2.72%. CONCLUSIONS: NLR is an independent prognostic factor for gastric cancer, especially in patients < 50 years old. A preoperative prediction nomogram using NLR can predict prognosis of gastric cancer as effectively as pTNM and a historical postoperative prediction nomogram.
Authors: Mi Ran Jung; Young Kyu Park; Oh Jeong; Jang Won Seon; Seong Yeob Ryu; Dong Yi Kim; Young Jin Kim Journal: J Surg Oncol Date: 2011-05-25 Impact factor: 3.454
Authors: Matthew M Hsieh; James E Everhart; Danita D Byrd-Holt; John F Tisdale; Griffin P Rodgers Journal: Ann Intern Med Date: 2007-04-03 Impact factor: 25.391
Authors: Louise W Treffers; Ida H Hiemstra; Taco W Kuijpers; Timo K van den Berg; Hanke L Matlung Journal: Immunol Rev Date: 2016-09 Impact factor: 12.988
Authors: Janesh Pillay; Bart P Ramakers; Vera M Kamp; Adele Lo Tam Loi; Siu W Lam; Falco Hietbrink; Luke P Leenen; Anton T Tool; Peter Pickkers; Leo Koenderman Journal: J Leukoc Biol Date: 2010-04-16 Impact factor: 4.962
Authors: Steven C H Kao; Nick Pavlakis; Rozelle Harvie; Janette L Vardy; Michael J Boyer; Nico van Zandwijk; Stephen J Clarke Journal: Clin Cancer Res Date: 2010-10-18 Impact factor: 12.531
Authors: Charlotte Summers; Sara M Rankin; Alison M Condliffe; Nanak Singh; A Michael Peters; Edwin R Chilvers Journal: Trends Immunol Date: 2010-08 Impact factor: 16.687
Authors: Chris P Verschoor; Jennie Johnstone; Jamie Millar; Michael G Dorrington; Mojtaba Habibagahi; Alina Lelic; Mark Loeb; Jonathan L Bramson; Dawn M E Bowdish Journal: J Leukoc Biol Date: 2013-01-22 Impact factor: 4.962
Authors: Masaya Nakauchi; Colin M Court; Laura H Tang; Mithat Gönen; Yelena Y Janjigian; Steven B Maron; Daniela Molena; Daniel G Coit; Murray F Brennan; Vivian E Strong Journal: J Am Coll Surg Date: 2022-04-28 Impact factor: 6.532